Novel Ex Vivo Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research

Epithelial ovarian cancer (EOC) is a heterogenous disease associated with variations in presentation, pathology and prognosis. Advanced EOC is typified by frequent relapse and a historical 5-year survival of less than 30% despite improvements in surgical and systemic treatment. The advent of next ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, James, Fotopoulou, Christina, Cunnea, Paula, Krell, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990887/
https://www.ncbi.nlm.nih.gov/pubmed/35402223
http://dx.doi.org/10.3389/fonc.2022.837233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990887/
https://www.ncbi.nlm.nih.gov/pubmed/35402223
http://dx.doi.org/10.3389/fonc.2022.837233

Ejemplares similares